Fulgent Genetics, Inc.
FLGT
$19.45
-$0.45-2.26%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -65.38% | -81.01% | -41.69% | 73.94% | 68.78% |
| Total Depreciation and Amortization | 7.23% | 0.08% | -3.23% | -4.22% | -6.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -27.89% | 5.61% | 13.69% | -69.46% | -65.48% |
| Change in Net Operating Assets | -17.85% | -315.19% | -1,525.00% | -125.34% | -4,290.59% |
| Cash from Operations | -233.55% | -1,062.41% | -582.61% | -86.12% | -168.33% |
| Capital Expenditure | 42.37% | 43.73% | 44.01% | 46.09% | -39.27% |
| Sale of Property, Plant, and Equipment | -72.50% | -80.70% | -98.40% | -99.23% | -93.67% |
| Cash Acquisitions | -- | -- | -- | 1,046.12% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 68.08% | 194.73% | 809.35% | 175.75% | 233.14% |
| Cash from Investing | 46.78% | 471.04% | 290.86% | 1,197.96% | 1,303.11% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 14.29% | 44.05% | 50.96% | 74.59% | 81.55% |
| Issuance of Common Stock | -76.47% | -80.39% | -98.04% | -- | -- |
| Repurchase of Common Stock | -402.00% | -304.24% | -345.58% | 48.94% | 52.68% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -376.31% | -266.71% | -205.12% | 52.14% | 57.23% |
| Foreign Exchange rate Adjustments | 376.32% | 288.00% | 290.91% | -146.43% | 177.55% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -368.84% | -444.47% | 88.27% | 330.12% | 238.67% |